Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) News
New Biotech Startup Looks to Take On Pfizer, Moderna
Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.
5 Top Stock Gainers for Wednesday: Michaels, Alcoa, Ovid Therapeutics
Michaels, Alcoa, Horizon Acquisition, KemPharm and Ovid Therapeutics are five top gainers for Wednesday.
Novavax Loss Widens, Revenue Jumps as COVID Vaccine Effort Progresses
Novavax's loss widened on a big jump in revenue, as the biotech's CEO said it's making 'significant strides' toward bringing a COVID-19 vaccine to market.
Sec. Alex Azar: Antibody Treatments, Vaccines 'Weeks' Away
Former FDA doc calls Azar's claim 'happy talk' as most experts expect a much longer time before widespread rollout of either a vaccine or effective treatment.
Blackstone Agrees to Buy Takeda Pharmaceutical Unit for $2.3 Billion
Takeda Consumer Healthcare is a leading provider of over-the-counter medicines in Japan.
FDA OKs Plasma Treatment for Ill Covid-19 Patients
Plasma treatment would use antibodies of those who recovered from Covid-19.
Novavax Plunges for a Second Day on Revenue Miss, Vaccine Uncertainty
Many experts remain uncertain about whether a vaccine from Novavax will be successful and beat the multiple other candidates to market.
5 Stock Gainers for Monday: Nikola, Silvercorp Metals, Trevena
Nikola, Silvercorp Metals, Renewable Energy Group, Trevena and Novavax are some of Monday's top gainers.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Apple Preparing For iPhone 14 Launch On September 7 - Report
Bloomberg reported late Wednesday that Apple is eyeing a September 7 launch date for its new iPhone 14 series.
Bed, Bath & Beyond Stock Dives As Ryan Cohen Moves to Sell Entire Stake
Ryan Cohen, who pushed for changes at Bed, Bath & Beyond including the ouster of CEO Mark Tritton, is looking to dump his entire 11.8% stake in the struggling home retailer.
Elon Musk Takes a Controversial Stand on Gender Equality
The richest man in the world sees himself as a global CEO, speaking his mind on just about anything.